Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azilsartan in elderly patients with hypertension and sarcopenia
ChiCTR2300071464Phase 4Not yet recruiting
- Sponsor
- Sir Run-Run Shaw Hospital
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of azilsartan in hypertension (HTN) and Sarcopenia (2 arms), sponsored by Sir Run-Run Shaw Hospital. Primary endpoints: 24-hour ambulatory blood pressure, Office blood pressure and 4 more. Planned start Jan 2023; status: not yet recruiting.
02
Drugs
azilsartan
03
Conditions
hypertension (HTN)Sarcopenia
Beyond the preview
Go deeper on ChiCTR2300071464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071464.